Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene

作者: Xiaofeng Wang , Lu Chen , Zhongdi Xiao , Yali Wang , Tiemei Liu

DOI: 10.3892/OL.2016.4966

关键词: Therapeutic gene modulationPromoterGene expressionCellular differentiationBiologyReporter genePAX4Stem cellMolecular biologyGene

摘要: Cluster of differentiation (CD)133 is an important cell surface marker glioma stem cells (GSCs). The transcription the CD133 gene controlled by five alternative promoters (P1, P2, P3, P4 and P5), which are expressed in a tissue-specific manner. In present study, recombination technology was used to construct two types expression vectors that contained P1 promoter gene, regulated either neomycin-resistance or herpes simplex virus thymidine kinase (HSV-TK) gene. Following stable transfection U251 glioblastoma with these vectors, expressing were named (+) cells, while regulating HSV-TK called (-) cells. detected flow cytometry reverse transcription-quantitative polymerase chain reaction. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay assess proliferation ability, cycle analyzed cytometry, clone formation test performed evaluate invasive capability results demonstrated that, due expression, ability significantly higher than those conclusion, study successfully established novel method screening GSCs based on

参考文章(26)
TING SUN, GUILIN CHEN, YANYAN LI, XUESHUN XIE, YOUXIN ZHOU, ZIWEI DU, Aggressive invasion is observed in CD133‑/A2B5+ glioma-initiating cells Oncology Letters. ,vol. 10, pp. 3399- 3406 ,(2015) , 10.3892/OL.2015.3823
Cheng Zhang, Wang, Du, Wang, Wu, Wang, Wang, Cao, Hamid, Zhang, Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation. OncoTargets and Therapy. ,vol. 5, pp. 143- 152 ,(2012) , 10.2147/OTT.S32918
Forrest M. Kievit, Stephen J. Florczyk, Matthew C. Leung, Kui Wang, Jennifer D. Wu, John R. Silber, Richard G. Ellenbogen, Jerry S.H. Lee, Miqin Zhang, Proliferation and enrichment of CD133+ glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds Biomaterials. ,vol. 35, pp. 9137- 9143 ,(2014) , 10.1016/J.BIOMATERIALS.2014.07.037
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine, SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma Cell Stem Cell. ,vol. 4, pp. 440- 452 ,(2009) , 10.1016/J.STEM.2009.03.003
Mikel Gurrea, Jianhui Zhu, Smathorn Thakolwiboon, Jason A. Heth, Karin M. Muraszko, Xing Fan, David M. Lubman, Song Nie, Tenascin-C: A Novel Candidate Marker for Cancer Stem Cells in Glioblastoma Identified by Tissue Microarrays Journal of Proteome Research. ,vol. 14, pp. 814- 822 ,(2015) , 10.1021/PR5008653
Angelo L. Vescovi, Rossella Galli, Brent A. Reynolds, Brain tumour stem cells Nature Reviews Cancer. ,vol. 6, pp. 425- 436 ,(2006) , 10.1038/NRC1889
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke, Jeremy A. Squire, Jane Bayani, Takuichiro Hide, R. Mark Henkelman, Michael D. Cusimano, Peter B. Dirks, Identification of human brain tumour initiating cells Nature. ,vol. 432, pp. 396- 401 ,(2004) , 10.1038/NATURE03128
Joseph Najbauer, Nikola Kraljik, Péter Németh, Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin. Pathology & Oncology Research. ,vol. 20, pp. 789- 797 ,(2014) , 10.1007/S12253-014-9837-Z
ABDU SELIM HAMID, JINRAN LI, YALI WANG, XIAODONG WU, HASSAN ABDELLAH AHMED ALI, ZHENWU DU, LIHUA BO, YUCHENG ZHANG, GUIZHEN ZHANG, Recombinant human decorin upregulates p57KIP2 expression in HepG2 hepatoma cell lines Molecular Medicine Reports. ,vol. 8, pp. 511- 516 ,(2013) , 10.3892/MMR.2013.1510
Kyeung Min Joo, Shi Yean Kim, Xun Jin, Sang Yong Song, Doo-Sik Kong, Jung-II Lee, Ji Won Jeon, Mi Hyan Kim, Bong Gu Kang, Yong Jung, Juyoun Jin, Seung-Chyul Hong, Woong-Yang Park, Dong-Sup Lee, Hyunggee Kim, Do-Hyun Nam, Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Laboratory Investigation. ,vol. 88, pp. 808- 815 ,(2008) , 10.1038/LABINVEST.2008.57